Last Updated: May 20, 2016
- PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer - pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.
Loibl S, et al. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2016 5 - Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.
Mirecka Alicja, et al. Pathology oncology research : POR 2016 5 - Defective ‘breast cancer’ genes aren’t just dangerous for women. They’re also linked to aggressive cancer in men.
By Laurie McGinley, the Washington Post, May 15, 2016 - Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.
Li Hongyan et al. Genetics in medicine : official journal of the American College of Medical Genetics 2016 May - Evaluation of the Relationship Between Family History of Breast Cancer and Risk Perception and Impacts on Repetition of Mammography.
Khoshravesh Sahar et al. Asian Pacific journal of cancer prevention : APJCP 2016 17 Spec No.135-41 - Genetic Instability in Locus rs5498 E469K (A/G) of ICAM-1 Gene in Patients with Colorectal Cancer and Breast Cancer.
Novikov V V, et al. Bulletin of experimental biology and medicine 2016 5 - Profound reduction in tamoxifen active metabolite endoxifen in a breast cancer patient treated with rifampin prior to initiation of an anti-TNF? biologic for ulcerative colitis: a case report.
Henderson Sara L, et al. BMC cancer 2016 0 304 - Role of MTHFR C677T and MTR A2756G polymorphisms in thyroid and breast cancer development.
Zara-Lopes T, et al. Genetics and molecular research : GMR 2016 0 (2) - Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant.
Spoerke Jill M, et al. Nature communications 2016 0 11579 - Analysis of CYP17, CYP19 and CYP1A1 Gene Polymorphisms in Iranian Women with Breast Cancer.
Farzaneh Farah, et al. Asian Pacific journal of cancer prevention : APJCP 2016 0 23-6 - Mutation Spectra of BRCA Genes in Iranian Women with Early Onset Breast Cancer - 15 Years Experience.
Yassaee Vahid Reza, et al. Asian Pacific journal of cancer prevention : APJCP 2016 0 149-53 - XRCC1 Gene Polymorphisms and Breast Cancer Risk: A Systematic Review and Meta- Analysis Study.
Sanjari Moghaddam Ali, et al. Asian Pacific journal of cancer prevention : APJCP 2016 0 323-30 - Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study.
Pellegrino Benedetta, et al. Acta bio-medica : Atenei Parmensis 2016 0 (1) 54-63 - Genome-Wide Analysis Identifies Germ-Line Risk Factors Associated with Canine Mammary Tumours.
Melin Malin, et al. PLoS genetics 2016 5 (5) e1006029 - Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of familial breast cancer.
Lee Haiping, et al. Mitochondrial DNA. Part A. DNA mapping, sequencing, and analysis 2016 9 (5) 3082-5 - Analysis of APOBEC3A/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation.
Revathidevi Sundaramoorthy, et al. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 5 - Patient-Centered Communication for Discussing Oncotype DX Testing.
Roberts Megan C et al. Cancer investigation 2016 Apr 1-8 - Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
Maxwell Kara N et al. American journal of human genetics 2016 May 98(5) 801-17 - Ovarian cancer in BRCA1/2 mutation carriers: The impact of mutation position and family history on the cancer risk.
Teixeira Natalia et al. Maturitas 2015 Oct 82(2) 197-202 - RAD51B in Familial Breast Cancer.
Pelttari Liisa M, et al. PloS one 2016 0 (5) e0153788 - Vitamin D Receptor Polymorphism and Breast Cancer Risk: A Meta-Analysis.
Lu Demin, et al. Medicine 2016 5 (18) e3535 - Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression.
Templeton Arnoud J, et al. PloS one 2016 0 (5) e0154789 - A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.
Bastos E P, et al. PloS one 2016 0 (5) e0154325 - Plasma phospholipids fatty acids, dietary fatty acids, and breast cancer risk.
Bassett Julie K, et al. Cancer causes & control : CCC 2016 5 - Differences of Variable Number Tandem Repeats in XRCC5 Promoter Are Associated with Increased or Decreased Risk of Breast Cancer in BRCA Gene Mutation Carriers.
Cui Jian, et al. Frontiers in oncology 2016 0 92 - A functional single nucleotide polymorphism of SET8 is prognostic for breast cancer.
Liu Ben, et al. Oncotarget 2016 4 - ABCB1 C3435T GENE POLYMORPHISM AS A POTENTIAL BIOMARKER OF CLINICAL OUTCOMES IN HER2-POSITIVE BREAST CANCER PATIENTS.
Madrid-Paredes Adela, et al. Pharmacological research 2016 4 - Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.
Gampenrieder S P, et al. The pharmacogenomics journal 2016 5 - JAX Genomics Education: Cancer Risk Assessment, Testing & Management
Disease: Lynch syndrome|Breast Cancer|Ovarian Cancer; Type: Education; State: Multiple States - Clinical and pathological features of BRCA1/2 tumors in a sample of high-risk Moroccan breast cancer patients.
Jouhadi Hassan, et al. BMC research notes 2016 0 (1) 248
- Human (0)
- Pathogen (1)
- Human (5155)
- Pathogen (0)
- Human (420)
- Pathogen (0)
.png)
No hay comentarios:
Publicar un comentario